MicroPort<sup>®</sup> Introduces its Transcatheter Aortic Valve in China Valve

Hangzhou, China – Shanghai MicroPort Medical (Group) Co ("MicroPort®") recently attended the Second China Valve (Hangzhou) to promote its in-house developed Self-expanding Transcatheter Aortic Valve.
 
The conference, hosted by the Second Affiliated Hospital of Zhejiang University School of Medicine, provides up-to-date information of the development of Transcatheter Aortic Valve Replacement ("TAVR") through academic lectures, case studies, panel discussions and simulating operations. Its Bureau was composed of more than 10 renowned experts from Germany, France, Canada, the US and the UK. Professor Runlin Gao of Fuwai Hospital of Chinese Academy of Medical Sciences, Professor Junbo Ge of Zhongshan Hospital, and Professor Yaling Han of the General Hospital of Shenyang Military, attended the conference.
 
The conference made a live broadcasting of TAVR therapy using MicroPort® Self-expanding Transcatheter Aortic Valve, Transcatheter Aortic Valve Delivery System and Valve Balloon Dilatation Catheter. Performed by Professor Jian'an Wang of the Second Affiliated Hospital of Zhejiang University School of Medicine and his team, the surgery achieved successful outcome and attracted wide attention from the audience.
 
Meanwhile, Professor Daxin Zhou of Zhongshan Hospital introduced the clinical advances of the Self-expanding Transcatheter Aortic Valve and Delivery System in detail. He pointed out: "MicroPort® products are proved effective as they significantly reduce aortic valve gradient. They are also safe and easy to operate."
 
TAVR is a revolutionary procedure to treat patients with aortic valve disease. With less pain and faster recovery, TAVR could bring better experience for patients in most cases. For patients who are too sick or too old for conventional operations, it could mean a life-saving opportunity. It is expected that MicroPort's domestically made valve will promote the use of TAVR so as to benefit more patients in China.
 
MicroPort®'s Self-expanding Transcatheter Aortic Valve is designed to have better coaxiality, anchoring and crossing ability, and most importantly it can reduce perivalvular leak. It is also easier to use with motorized handle.